CareDx Inc (NAS:CDNA)
$ 46.69 +1.88 (+4.2%) Market Cap: 2.42 Bil Enterprise Value: 2.06 Bil PE Ratio: 22.56 PB Ratio: 5.65 GF Score: 67/100

CareDx Inc at Goldman Sachs Healthcare Conference Transcript

Jun 08, 2026 / 05:20PM GMT
Release Date Price: $21.95 (-1.35%)
Evie Koslosky
Goldman Sachs - Analyst

Good afternoon, everyone. I'm Evie Koslosky, Head of the Life Science Tools and Diagnostics team here at Goldman Sachs. I'm joined here today with CareDX. So thank you for coming.

John Hanna
CareDx Inc - President, Chief Executive Officer, Director

Thanks so much for having us, Evie. We really appreciate it. I'm John Hanna. I'm the CEO here at CareDX, and I'm joined by Keith Kennedy, our COO and CFO.

Questions & Answers

Evie Koslosky
Goldman Sachs - Analyst

Great. So I guess just to kind of kick things off, your strategy since joining the company as CEO, John, has been to transform CareDx into a precision oncology leader. I guess, can you talk through the strategy and what this means at a high level and key initiatives that you have in place to kind of achieve this precision medicine goal?

John Hanna
CareDx Inc - President, Chief Executive Officer, Director

Yeah, thanks so much. We really view CareDx as a precision

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot